MedTrace Logo

Sepsis and Myocarditis

NCT07079605 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 226

Last updated 2025-07-23

No results posted yet for this study

Summary

This prospective cohort study aims to investigate the cardiac manifestations of sepsis and their influence on disease outcomes among adult patients at Jimma University Medical Center, Ethiopia, from May 2025 to May 2026. The research will include adults aged 18 and older with sepsis, categorizing them based on the presence or absence of cardiac involvement, which will be assessed through clinical symptoms, biomarkers, ECG, and echocardiographic findings. The study will evaluate the persistence of cardiac abnormalities, functional capacity, and survival over one year, utilizing structured data collection and advanced statistical methods, including survival analysis and regression techniques, to identify predictors of adverse outcomes.

Conditions

  • Sepsis-related Myocarditis

Interventions

OTHER

Standard treatment for sepsis of any focus

This group of patients will be treated for the sepsis of any focus as per standard.

OTHER

Treatment for the sepsis with standard management of cardiac failure

This group of patients will be treated for the sepsis and management of cardiac failure with additional supportive care cocktails based on the specific indication.

Sponsors & Collaborators

  • Ethiopian Society of Cardiac Professionals

    collaborator UNKNOWN

  • Jimma University

    lead OTHER

Principal Investigators

  • Nikolaus Alexander Haas, MD, Pediatician, Cardiologist · Ludwig Maximillians University of Munich, Germany

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-09
Primary Completion
2026-05-08
Completion
2026-09-22

Countries

  • Ethiopia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07079605 on ClinicalTrials.gov